OXOID Streptococcal Grouping Kit - HSA Registration DE0015996
Access comprehensive regulatory information for OXOID Streptococcal Grouping Kit in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0015996 and owned by OXOID Limited. The device was registered on July 17, 2014.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
A latex agglutination test for the identification of streptococcal groups A, B, C, D, F, and G Lancefield showed that the majority of pathogenic streptococci possess specific carbohydrate antigens, which permit the classification of streptococci into groups. These streptococcal group antigens can be extracted from the cells and their presence demonstrated with latex particles previously coated with group-specific antibodies. These latex particles will agglutinate in the presence of homologous antigen, but will remain in smooth suspension in the absence of such antigen. The Oxoid Streptococcal Grouping Kit is such a latex agglutination test for the identification of the streptococcal group, and reagents are provided for groups, A, B, C, D, F, and G. The use of a new enzymatic extraction procedure considerably shortens the time required for antigen extraction and much improves the antigen yield, particularly for Group D streptococci.